132 related articles for article (PubMed ID: 37747815)
1. An integrated analysis identifies six molecular subtypes of pancreatic ductal adenocarcinoma revealing cellular and molecular landscape.
Li L; Shen L; Wu H; Li M; Chen L; Zhou Q; Ma J; Huai C; Zhou W; Wei M; Zhao M; Zhao X; Du H; Jiang B; Sun Y; Zhang N; Qin S; Xing T
Carcinogenesis; 2023 Dec; 44(10-11):726-740. PubMed ID: 37747815
[TBL] [Abstract][Full Text] [Related]
2. Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.
Puleo F; Nicolle R; Blum Y; Cros J; Marisa L; Demetter P; Quertinmont E; Svrcek M; Elarouci N; Iovanna J; Franchimont D; Verset L; Galdon MG; Devière J; de Reyniès A; Laurent-Puig P; Van Laethem JL; Bachet JB; Maréchal R
Gastroenterology; 2018 Dec; 155(6):1999-2013.e3. PubMed ID: 30165049
[TBL] [Abstract][Full Text] [Related]
3. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
Huang H; Brekken RA
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
[TBL] [Abstract][Full Text] [Related]
5. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
[TBL] [Abstract][Full Text] [Related]
6. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
Front Immunol; 2021; 12():690056. PubMed ID: 34335594
[TBL] [Abstract][Full Text] [Related]
8. T-cell programming in pancreatic adenocarcinoma: a review.
Seo YD; Pillarisetty VG
Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
[TBL] [Abstract][Full Text] [Related]
9. Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma.
Croft W; Pearce H; Margielewska-Davies S; Lim L; Nicol SM; Zayou F; Blakeway D; Marcon F; Powell-Brett S; Mahon B; Merard R; Zuo J; Middleton G; Roberts K; Brown RM; Moss P
Elife; 2023 Jun; 12():. PubMed ID: 37350578
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival.
Lyu SI; Krey T; Damanakis AI; Zhao Y; Bruns CJ; Schmidt T; Popp FC; Quaas A; Knipper K;
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7539-7546. PubMed ID: 36971797
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
Zhao L; Zhao H; Yan H
BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
[TBL] [Abstract][Full Text] [Related]
12. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.
Elyada E; Bolisetty M; Laise P; Flynn WF; Courtois ET; Burkhart RA; Teinor JA; Belleau P; Biffi G; Lucito MS; Sivajothi S; Armstrong TD; Engle DD; Yu KH; Hao Y; Wolfgang CL; Park Y; Preall J; Jaffee EM; Califano A; Robson P; Tuveson DA
Cancer Discov; 2019 Aug; 9(8):1102-1123. PubMed ID: 31197017
[TBL] [Abstract][Full Text] [Related]
13. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment.
Xue M; Zhu Y; Jiang Y; Han L; Shi M; Su R; Wang L; Xiong C; Wang C; Wang T; Deng S; Wu D; Cao Y; Dong L; Bai F; Zhao S; Deng X; Peng C; Li H; Chen J; Shen B; Jiang L; Chen H
Nat Commun; 2023 Jul; 14(1):4600. PubMed ID: 37524695
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Zhang T; Ren Y; Yang P; Wang J; Zhou H
Cell Death Dis; 2022 Oct; 13(10):897. PubMed ID: 36284087
[TBL] [Abstract][Full Text] [Related]
15. A quantitative score of immune cell infiltration predicts the prognosis in pancreatic ductal adenocarcinoma.
Chen ZG; Wang Y; Fong WP; Hu MT; Liang JY; Wang L; Li YH
Int Immunopharmacol; 2021 Sep; 98():107890. PubMed ID: 34174701
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
Feldmann K; Maurer C; Peschke K; Teller S; Schuck K; Steiger K; Engleitner T; Öllinger R; Nomura A; Wirges N; Papargyriou A; Jahan Sarker RS; Ranjan RA; Dantes Z; Weichert W; Rustgi AK; Schmid RM; Rad R; Schneider G; Saur D; Reichert M
Gastroenterology; 2021 Jan; 160(1):346-361.e24. PubMed ID: 33007300
[TBL] [Abstract][Full Text] [Related]
17. The pancreas cancer microenvironment.
Feig C; Gopinathan A; Neesse A; Chan DS; Cook N; Tuveson DA
Clin Cancer Res; 2012 Aug; 18(16):4266-76. PubMed ID: 22896693
[TBL] [Abstract][Full Text] [Related]
18. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
[TBL] [Abstract][Full Text] [Related]
19. Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype.
Oh K; Yoo YJ; Torre-Healy LA; Rao M; Fassler D; Wang P; Caponegro M; Gao M; Kim J; Sasson A; Georgakis G; Powers S; Moffitt RA
Nat Commun; 2023 Aug; 14(1):5226. PubMed ID: 37633924
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target.
Pandey R; Zhou M; Islam S; Chen B; Barker NK; Langlais P; Srivastava A; Luo M; Cooke LS; Weterings E; Mahadevan D
Sci Rep; 2019 Dec; 9(1):18347. PubMed ID: 31797958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
